• Biocelect

TGA Approves Kodatef

Biocelect welcomes Australia's Therapeutic Goods Administration (TGA) approval of KODATEF (tafenoquine); the first malaria prevention drug approved in Australia in more than two decades

Biocelect Welcomes TGA Approval of KODAT
Download • 500KB

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon